<?xml version="1.0" encoding="UTF-8" standalone="yes"?><Drug id="64656" name="nusinersen"><HDS>Launched</HDS><RegulatoryDesignations><RegulatoryDesignation id="2">Fast Track</RegulatoryDesignation><RegulatoryDesignation id="1">Orphan Drug</RegulatoryDesignation><RegulatoryDesignation id="9">Paediatric Investigation Plan</RegulatoryDesignation><RegulatoryDesignation id="11">Priority Review</RegulatoryDesignation><RegulatoryDesignation id="13">Rare Pediatric Disease</RegulatoryDesignation></RegulatoryDesignations><Actions><Action id="1615" type="secondary">Neuroprotectant</Action><Action id="172638" type="secondary">SMN2 gene modulator</Action><Action id="7294" type="secondary">Antisense oligonucleotide inhibitor</Action></Actions><Indications><Indication id="727" type="primary">Spinal muscular atrophy</Indication></Indications><Entities><Entity>Biological</Entity></Entities><OriginatorCompany id="17269">Ionis Pharmaceuticals Inc</OriginatorCompany></Drug>